(1S)-(+)-(10-Camphorsulfonyl) oxaziridine CAS 104322-63-6 Puritas ≥98.5%

Description:

Nomen: (1S)-(+)-(10-Camphorsulfonyl) oxaziridine

Synonyma: (2R,8aS)-(+)-(Camphorylsulfonyl) oxaziridinum

CAS: 104322-63-6

Aspectus: Off-White vel pallide Yellow Crystallina pulveris

Puritas: ≥98.5% (HPLC)

Chiral Compounds, Commercial Production

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer Supple cum High puritate et stabulo Quality
(1S)-(+)-(10-Camphorsulfonyl) oxaziridine CAS 104322-63-6
(1R)-(-)-(10-Camphorsulfonyl) oxaziridine CAS 104372-31-8
Chiral Compounds, High Quality, Commercial Production

Chemical Properties:

Nomen chemicum	(1S)-(+)-(10-Camphorsulfonyl) oxaziridine
Synonyma	(1S)-(+)-(Camphorylsulfonyl) oxaziridine;(2R,8aS)-(+)-(Camphorylsulfonyl) oxaziridine
CAS Number	104322-63-6
CATTUS Number	RF-CC267
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C10H15NO3S
M. Pondus	229.3
Shipping Condition	Uit sub Ambient Temperature
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Off-Alba vel lutea Crystallina pulveris
Puritas	≥98.5% (HPLC)
Liquescens punctum	168.0~172.0℃
Imprimis Rotationes [a]D20	+43.0° ~ +47.0° (C=2.3, In CHCl3).
Damnum in Siccatio	≤1.0%
Residere in Ignition	≤0.30%
Metalla gravia (Pb)	≤20ppm
Test Standard	Enterprise Standard
Consuetudinem	Chiral Compositions;Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard Drum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum (1S)-(+)-(10-Camphorsulfonyl)oxaziridine (CAS: 104322-63-6) magna qualitate.

(1S)-(+)-(10-Camphorsulfonyl)oxaziridine (CAS: 104322-63-6) utilis est derivativa Camphorae, media utilis synthetica.Usus est pro hydroxylatione asymmetrica.

(CAS: 104322-63-6) adhiberi possunt:
Ad ketonem prochiralem convertendi enolate in ketones optice activos α-hydroxy per oxidationem asymmetricam enantioselectivam.
In synthesi thymidini oligonucleotidis per pyrophosphates connexae.
In synthesi asymmetrica sentinarum protonica inhibitores sicut (R) -Rabeprazole sodium et -Lansoprazole sodium ex DBU sal sulfidis prochiralis respondente.
In praeparatione phosphonoacetatis et thiophosphonoacetatis oligodeoxynucleotides per oxidizing phosphinoacetate correspondentes.